Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years - Concepedia

Concepedia

Publication | Closed Access

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

352

Citations

28

References

2009

Year

Unknown Author(s)

VaccinationHuman Papillomavirus VaccinesAs04-adjuvanted VaccineVaccine SurveillanceImmunodeficienciesImmunologyVaccine TestingVaccine EfficacyHuman PapillomavirusMedicineVaccine ResearchRandomised Placebo-controlled Trial

References

	Year	Citations

Page 1